Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis

被引：0
|
作者：
P Guglielmelli
F Biamonte
A Spolverini
L Pieri
A Isgrò
E Antonioli
A Pancrazzi
A Bosi
G Barosi
A M Vannucchi
机构：
[1] Unità Funzionale di Ematologia,Dipartimento di Area Critica
[2] Università degli Studi,undefined
[3] Istituto Toscano Tumori,undefined
[4] Unità di Epidemiologia Clinica-Centro per lo Studio della Mielofibrosi,undefined
[5] Fondazione IRCCS Policlinico San Matteo,undefined
来源：
Leukemia | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1533 / 1537
页数：4
相关论文
共 50 条
  • [41] JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential
    Campiotti, Leonardo
    Elli, Lorenzo
    Suter, Matteo B.
    Guasti, Luigina
    Pallotti, Francesco
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (01) : E24 - E26
  • [42] JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms
    Wang, J.
    Xu, Z.
    Liu, L.
    Gale, R. P.
    Cross, N. C. P.
    Jones, A. V.
    Qin, T.
    Ai, X.
    Xu, J.
    Zhang, T.
    Sun, X.
    Li, Q.
    Zhang, P.
    Zhang, Y.
    Xiao, Z.
    LEUKEMIA, 2013, 27 (08) : 1763 - 1767
  • [43] JAK2V617F allele burden, JAK2 46/1 haplotype and clinical features of Chinese with myeloproliferative neoplasms
    J Wang
    Z Xu
    L Liu
    R P Gale
    N C P Cross
    A V Jones
    T Qin
    X Ai
    J Xu
    T Zhang
    X Sun
    Q Li
    P Zhang
    Y Zhang
    Z Xiao
    Leukemia, 2013, 27 : 1763 - 1767
  • [44] The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis
    Zerjavic, Katja
    Zagradisnik, Boris
    Lokar, Lidija
    Krasevac, Marjana G.
    Vokac, Nadja K.
    THROMBOSIS RESEARCH, 2013, 132 (02) : E86 - E93
  • [45] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Tanaka, Mayumi
    Yujiri, Toshiaki
    Ito, Shunsuke
    Okayama, Naoko
    Takahashi, Toru
    Shinohara, Kenji
    Azuno, Yoichi
    Nawata, Ryouhei
    Hinoda, Yuji
    Tanizawa, Yukio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 409 - 413
  • [46] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Brazilian patients
    Macedo, L. C.
    Santos, B. C.
    Pagliarini-E-Silva, S.
    Pagnano, K. B. B.
    Rodrigues, C.
    Quintero, F. C.
    Ferreira, M. E.
    Baraldi, E. C.
    Ambrosio-Albuquerque, E. P.
    Sell, A. M.
    Visentainer, J. E. L.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 654 - 660
  • [47] TARGETED NEXT-GENERATION SEQUENCING IDENTIFIES NOVEL GENE VARIANTS IN JAK2V617F NEGATIVE PATIENTS WITH ERYTHROCYTOSIS AND JAK2 GGCC_46/1 HAPLOTYPE
    Anelli, L.
    Orsini, P.
    Minervini, A.
    Zagaria, A.
    Coccaro, N.
    Parciante, E.
    Minervini, C. F.
    Cumbo, C.
    Tota, G.
    Impera, L.
    Ricco, A.
    Conserva, M. R.
    Specchia, G.
    Albano, F.
    HAEMATOLOGICA, 2019, 104 : 15 - 15
  • [48] JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
    Mayumi Tanaka
    Toshiaki Yujiri
    Shunsuke Ito
    Naoko Okayama
    Toru Takahashi
    Kenji Shinohara
    Yoichi Azuno
    Ryouhei Nawata
    Yuji Hinoda
    Yukio Tanizawa
    International Journal of Hematology, 2013, 97 : 409 - 413
  • [49] The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status—clinical correlates in a study of 226 consecutive patients
    A Pardanani
    T L Lasho
    C M Finke
    N Gangat
    A P Wolanskyj
    C A Hanson
    A Tefferi
    Leukemia, 2010, 24 : 110 - 114
  • [50] THE JAK2 RS10974944 SNP, PART OF JAK2 46/1 HAPLOTYPE, STRONGLY PREDISPOSES TO JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS
    Trifa, A.
    Cucuianu, A.
    Petrov, L.
    Urian, L.
    Dima, D.
    Militaru, M.
    Pop, I.
    Popp, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 598 - 598
12345